193 related articles for article (PubMed ID: 7783335)
1. [Monitoring for oral anticoagulant therapy].
Nakagawa K; Nakahara Y; Tsuji H
Rinsho Ketsueki; 1995 Apr; 36(4):308-13. PubMed ID: 7783335
[TBL] [Abstract][Full Text] [Related]
2. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
[TBL] [Abstract][Full Text] [Related]
3. [International normalized ratio (INR) for optimal anticoagulant therapy].
Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
[TBL] [Abstract][Full Text] [Related]
4. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
5. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
[TBL] [Abstract][Full Text] [Related]
6. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
7. [Inter-institute variations in International Normalized Ratio and thrombotest].
Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between prothrombin time international normalized ratio and thrombo test (%)].
Numata Y; Ogata Y; Arao K; Mizumasa Y; Wakita T; Haruguchi H; Araki H; Tsuji T; Mawatari K; Shimada K
J Cardiol; 2001 Dec; 38(6):327-35. PubMed ID: 11806090
[TBL] [Abstract][Full Text] [Related]
9. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
Oertel LB
Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
12. Coagulant activity during one year after bioprosthetic aortic valve replacement.
Imagawa H; Ryugo M; Shikata F; Nakata T; Nagashima M; Kawachi K
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):417-20. PubMed ID: 19141491
[TBL] [Abstract][Full Text] [Related]
13. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories.
Uetsuka Y; Sakuragawa N; Wada H; Aizawa Y; Aosaki M
Semin Thromb Hemost; 2000; 26(1):109-12. PubMed ID: 10805291
[TBL] [Abstract][Full Text] [Related]
14. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
15. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
16. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
Sanfelippo MJ; Sennet J; McMahon EJ
WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
[TBL] [Abstract][Full Text] [Related]
17. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
[TBL] [Abstract][Full Text] [Related]
18. Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR.
Uetsuka Y; Hosoda S; Kasanuki H; Aosaki M; Murasaki K; Ooki K; Inoue M; Akiyama E; Kitada M
Heart Vessels; 2000; 15(3):124-8. PubMed ID: 11289500
[TBL] [Abstract][Full Text] [Related]
19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
20. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
Koefoed BG; Feddersen C; Gulløv AL; Petersen P
Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
